Company Overview and News

0
Vedanta mulls options for Indian iron ore workers after shutdown: Sources

2018-06-14 moneycontrol
Vedanta Resources is considering options including lay-offs for some of the 2,000 employees of its iron ore business in southwest India that was shut down by a court, two sources said, as it struggles with a series of setbacks in the country.
VED VEDL

2
UPDATE 1-UK Stocks-Factors to watch on June 12

2018-06-12 reuters
June 12 (Reuters) - Britain’s FTSE 100 index is seen opening up 10 points at 7,747 on Tuesday, according to financial bookmakers, with futures up 0.21 percent ahead of the cash market open.
CRTHF CRNHY VED RDL BATS 4162 TBAKY TBAKF TED

3
METALS-Copper slides as fears about supply disruptions wane

2018-06-11 reuters
LONDON, June 11 (Reuters) - Copper prices slid on Monday as fears about output disruption at the Escondida mine in Chile receded, but worries about supplies from Vedanta’s copper smelter in India and a softer dollar provided some support.
VED SCGLF SCGLY GLE

0
Police arresting Vedanta smelter protesters based on evidence: Minister

2018-06-11 moneycontrol
Police are only arresting people involved in protests against a copper smelter owned by Vedanta Resources where there is videographed evidence of them indulging in "anti-social" activities, a senior Tamil Nadu minister told Reuters.
VED

14
EXCLUSIVE: Tata Steel joins race for Usha Martin#39;s Jamshedpur unit

2018-06-07 moneycontrol
Tata Steel has joined the race for Usha Martin's Jamshedpur facility, which was put on the block to pare some of the parent's debt.
517146 500228 BHUSANSTL UHBTY JSWSTEEL USHAMART VED 500470 TTST TATASTEEL TATLY 500570 TATAMOTORS 500055 TTM

11
JSW Steel looks for stressed assets in India overseas, for its 50 mtpa target

2018-06-06 moneycontrol
After the successful acquisition of Italy's Aferpi, and the winning bid for Monnet Ispat in the domestic market, Sajjan Jindal-led JSW Steel is looking for more distressed assets in India and overseas.
USHAMART 517146 VED 500470 TTST TATASTEEL TATLY 500228 BHUSANSTL UHBTY JSWSTEEL 500055

9
Vedanta pays Rs5,320 crore for Electrosteel acquisition

2018-06-04 livemint
Mumbai: Billionaire Anil Agarwal’s Vedanta Ltd has taken over on Monday control of bankrupt company Electrosteel Steels Ltd, the former said in a regulatory filing.
ESL VED 500470 TTST TATASTEEL TATLY BHUSANSTL 533264 VEDL 500055

0
Exclusive: After deadly Indian smelter protests, arrests stoke tension

2018-06-03 reuters
THOOTHUKUDI, India (Reuters) - Eleven days after police in southern India fired on protesters seeking the shutdown of a copper smelter owned by London-listed Vedanta, killing 13, residents say people suspected of involvement in the demonstrations are being targeted in a wave of arrests.
VED

0
Exclusive: After deadly Indian smelter protests, arrests stoke tension

2018-06-03 channelnewsasia
Eleven days after police in southern India fired on protesters seeking the shutdown of a copper smelter owned by London-listed Vedanta, killing 13, residents say people suspected of involvement in the demonstrations are being targeted in a wave of arrests.
VED

0
Managing externalities: The case of Sterilite

2018-06-02 freepressjournal.in
Businessmen are mainly concerned with making profits. They live in a competitive world and they have to produce goods at the lowest possible cost. Their profits are determined by the payments made for the raw materials such as copper ore by the Sterilite plant in Tuticorin, cost of land, machinery and labour. The cost to the society from pollution of air and water does not enter into their calculations.
VED 532792 CAIRN CWNQY

0
Closure of Vedanta’s copper operations in India marginally credit negative: Moody’s

2018-06-01 livemint
New Delhi:The permanent closure of Vedanta Resources Plc’s copper operations in India is marginally credit negative as it will lower the company’s scale and business diversity, Moody’s Investors Service on Friday said.
VED

0
Fortis Healthcare appoints Ravi Rajagopal as chairman

2018-06-01 livemint
New Delhi: Fortis Healthcare on Friday said it has appointed Ravi Rajagopal as the chairman of the company’s board with immediate effect.
VED FORTIS 532843

9
NCLAT allows Vedanta to make Rs5,320 crore upfront payment for Electrosteel Steels

2018-05-30 livemint
New Delhi: The National Company Law Appellate Tribunal (NCLAT) on Wednesday permitted Vedanta Ltd to make an upfront payment of Rs5,320 crore to the Committee of Creditors (CoC) of debt-ridden Electrosteel Steels India Ltd, according to its approved debt resolution plan.
ESL VED 500470 TTST TATASTEEL TATLY 533264 VEDL SBAZ

0
METALS-Copper slips as Italy crisis and U.S.-China trade row feed risk aversion

2018-05-30 reuters
LONDON, May 30 (Reuters) - Copper fell to a three-week low on Wednesday as a retreat in stock markets on worries over political turmoil in Italy kept pressure on cyclical assets, offsetting a weaker dollar.
VED

0
Vedanta preparing legal challenge to Sterlite copper plant shutdown

2018-05-30 livemint
New Delhi: Vedanta Resources Plc is working on a legal challenge to Tamil Nadu ordering a permanent shutdown of the Sterlite copper plant in Thoothukudi, but it will not proceed until tensions over the deaths of 13 people during protests last week have eased, two people told Reuters.
VED

Related Articles

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

STML: Stemline Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Stemline Therapeutics was incorporated under the laws of the State of Delaware in August 2003. Stemline Therapeutics is a clinical stage biopharmaceutical company focused on discovering, acquiring, developing and potentially commercializing innovative oncology therapeutics that target difficult to treat cancers. The company's clinical pipeline includes: SL-401, SL-801, and SL-701. SL-401 pivotal data; plans for registration and potential commercialization: SL-401 has completed a pivotal trial in patients with blastic plasmacytoid dendritic cell neoplasm, or BPDCN, and has successfully met the primary endpoint of the trial. SL-401 is a targeted therapy directed to the interleukin-3 receptor-a, or CD123. SL-401 was granted breakthrough therapy designation, or BTD, by the U.S. Food and Drug Administration, or FDA, for the treatment of patients with BPDCN. Based on the trial results and other data, the company expect to complete submission of a rolling Biologics License...

Silicon Investor Message Boards

This table lists all message boards related to LSE:VED / VEDANTA RESOURCES on message board site Silicon Investor.

Medved QuoteTracker - real-time portfolio tracker The Vastly Improved Sauna
BEAT UP, NEGLECTED, UNKNOWN OR UNLOVED MICROS. Testing the New and Improved Create Subject Page
How I survived the Crash of 2000 Medved Qoutracker (Portfolio tracking software)
Vedron Gold (VDGI Unlisted) SI Postings Preserved for Posterity
Report on Business Television Archived Videos The Boxing Ring Revived